Beyond vancomycin: new therapies to meet the challenge of glycopeptide resistance
Authors:
- Thalia I. NicasTNThalia I. Nicas
- Michael L. ZeckelMZMichael L. Zeckel
- Daniel K. BraunDBDaniel K. Braun
- 30 June 1997
- journal article
- review article
- Published by Elsevier in Trends in Microbiology
- Vol. 5 (6) , 240-249
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- Superinfection with Enterococcus faecalis During Quinupristin/Dalfopristin TherapyClinical Infectious Diseases, 1997
- Quinupristin-DalfopristinDrugs, 1996
- Susceptibility of enterococci, methicillin-resistant Staphylococcus aureus and Streptococcus pneumoniae to the glycylcyclinesJournal of Antimicrobial Chemotherapy, 1995
- In-vitro activity of two glycylcyclines against enterococci resistant to other agentsJournal of Antimicrobial Chemotherapy, 1995
- Susceptibility of ciprofloxacin-resistant Staphylococci and Enterococci to clinafloxacinDiagnostic Microbiology and Infectious Disease, 1995
- Nosocomial Acquisition ofClostridium difficileInfectionNew England Journal of Medicine, 1989
- Plasmid-Mediated Resistance to Vancomycin and Teicoplanin in Enterococcus FaeciumNew England Journal of Medicine, 1988
- Synthèse et étude de marqueurs d'affinité analogues de la pristinamycine IAEuropean Journal of Medicinal Chemistry, 1988
- Emergence of Vancomycin Resistance in Coagulase-Negative StaphylococciNew England Journal of Medicine, 1987
- Predominance of two newly described capsular polysaccharide types among clinical isolates of Staphylococcus aureusDiagnostic Microbiology and Infectious Disease, 1984